【ChiCTR2400091460】A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
ChiCTR2400091460
尚未开始
/
/
/
2024-10-29
/
/
/
A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
The study is to evaluate the effectiveness of the group-based compassionate mind training (CMT) protocol on patients' psychopathology conditions, fears of compassion and self-compassion. The study would also consider participants' homework compliance in the evaluation of treatment outcomes.
随机平行对照
其它
Participants will be allocated to the intervention group or control group (1:1 ratio) randomly. A research assistant who is not involved in the intervention would generate the random numbers by computer.
/
Self-finance
/
64
/
2024-10-30
2025-12-31
/
Inclusion criteria: 1) aged 18 or above, 2) patients from psychiatric and/or clinical psychology outpatient clinics who are experiencing depressive disorders, particularly major depressive disorder, persistent depressive disorder, and other specified depressive disorder (operationalized as fulfilling the criteria in Diagnostic and Statistical Manual of Mental Disorders: Fifth edition, text revision (DSM-V-TR)). Clinical psychologists would further verify the diagnosis with reference to the DSM-V-TR criteria. 3) Meanwhile, recruited participants’ concurrent psychotrophic medications were said to be stable during the study.;
请登录查看Patients with neurodevelopmental disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorders, obsessive-compulsive disorders, comorbid substance use disorder, personality disorders, potential risks to self and/or others, neurocognitive disorders, intellectual disabilities, physical disabilities, severe medical illnesses (such as newly diagnosis at acute phase, potential to undergo intensive treatment), who could not read Chinese and speak in Cantonese, who did not read and write, as well as those who had previously received compassion-based or mindfulness-based interventions.;
请登录查看Department of Psychology, The Chinese University of Hong Kong
/
Department of Psychology, The Chinese University of Hong Kong的其他临床试验
Hospital Authority Hong Kong SAR的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

